These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30788039)

  • 1. Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer.
    Berghella AM; Aureli A; Canossi A; Beato TD; Colanardi A; Pellegrini P
    World J Gastrointest Oncol; 2019 Feb; 11(2):117-138. PubMed ID: 30788039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients.
    Contasta I; Totaro R; Berghella AM; Pellegrini P; Del Beato T; Carolei A; Adorno D
    Int J Immunopathol Pharmacol; 2010; 23(1):213-26. PubMed ID: 20378007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
    Contasta I; Berghella AM; Pellegrini P; Adorno D
    Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy.
    Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y
    Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.
    Sofi MH; Wu Y; Schutt SD; Dai M; Daenthanasanmak A; Heinrichs Voss J; Nguyen H; Bastian D; Iamsawat S; Selvam SP; Liu C; Maulik N; Ogretmen B; Jin J; Mehrotra S; Yu XZ
    J Clin Invest; 2019 May; 129(7):2760-2774. PubMed ID: 31045571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
    Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
    Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancer.
    Park SJ; Hong YS; Lee JL; Ryu MH; Chang HM; Kim KP; Ahn YC; Na YS; Jin DH; Yu CS; Kim JC; Kang YK; Kim TW
    Oncology; 2012; 82(2):83-9. PubMed ID: 22327884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
    Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
    Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
    Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma soluble CD30 level correlates negatively with age in children.
    Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
    J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration.
    Krampera M; Vinante F; Tavecchia L; Morosato L; Chilosi M; Romagnani S; Zanolin ME; Pizzolo G
    Clin Exp Immunol; 1999 Aug; 117(2):291-7. PubMed ID: 10444260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Thioredoxin1 enhances functional recovery in a mouse model of hind limb ischemia.
    Shaikh IA; Rishi MT; Youssef M; Selvaraju V; Thirunavukkarasu M; Ukani G; Lakshmanan R; Palesty JA; Maulik N
    J Surg Res; 2017 Aug; 216():158-168. PubMed ID: 28807201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1.
    Schwertassek U; Balmer Y; Gutscher M; Weingarten L; Preuss M; Engelhard J; Winkler M; Dick TP
    EMBO J; 2007 Jul; 26(13):3086-97. PubMed ID: 17557078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent changes of serum soluble CD30 concentration in children.
    Chrul S; Polakowska E
    Pediatr Transplant; 2011 Aug; 15(5):515-8. PubMed ID: 21672104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lens thioredoxin: molecular cloning and functional characterization.
    Yegorova S; Liu A; Lou MF
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3263-71. PubMed ID: 12882768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal redox dysregulation in AKI: application for oxidative stress marker of AKI.
    Kasuno K; Shirakawa K; Yoshida H; Mori K; Kimura H; Takahashi N; Nobukawa Y; Shigemi K; Tanabe S; Yamada N; Koshiji T; Nogaki F; Kusano H; Ono T; Uno K; Nakamura H; Yodoi J; Muso E; Iwano M
    Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1342-51. PubMed ID: 25350977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
    Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
    Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
    Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
    J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
    Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
    PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.